List of Demographics for Our Rural Chronic Non-Cancer Pain Patients: Differences Between the Intervention and Original Control Group before Intervention (n = 186)
| Demographic Variable | Intervention (n = 93) | Control (n = 93) | P value | Discussion |
|---|---|---|---|---|
| Gender* | ||||
| Females (%) | 51 (54.8) | 51 (54.8) | 1.00 | |
| Smoker* (%) | 63 (67.7) | 48 (51.6) | 0.04 | More smokers in intervention group |
| Use of Benzodiazepine before intervention* (%) | 23 (24.7) | 38 (40.9) | 0.03 | More Benzo. use in the control group before intervention |
| Use of Carisoprodol* (%) | 3 (3.2) | 4 (4.3) | 1.00 | |
| Positive substance abuse history* (%) | 36 (38.7) | 9 (9.7) | 0.00 | More substance abuse dx in the intervention group‡ |
| Age†(%) | 0.9 | |||
| 18 to 29 | 4 (4.3) | 4 (4.3) | ||
| 30 to 39 | 15 (16.1) | 13 (14) | ||
| 40 to 49 | 21 (22.6) | 28 (30.1) | ||
| 50 to 59 | 32 (34.4) | 21 (22.6) | ||
| 60–69 | 12 (12.9) | 18 (19.4) | ||
| 70–79 | 9 (9.7) | 7 (7.5) | ||
| 80 to 89 | 0 | 2 (2.2) | ||
| Insurance type§ (%) | 0.89 | |||
| Uninsured | 6 (6.5) | 4 (4.3) | ||
| Veterans | 1 (1.1) | 1 (1.1) | ||
| Medicare | 29 (31.2) | 35 (37.6) | ||
| Medicaid | 32 (34.4) | 30 (32.3) | ||
| Private | 25 (26.9) | 23 (24.7) | ||
| Psychiatric diagnose§ (%) | 0.03 | More generalized anxiety in the control group; more PTSD in the experimental group‡ | ||
| None | 27 (29) | 23 (24.7) | ||
| Depression | 40 (43) | 39 (41.9) | ||
| Anxiety d/o | 11 (11.8) | 26 (28) | ||
| Bipolar | 3 (3.2) | 2 (2.2) | ||
| PTSD | 11 (11.8) | 3 (3.2) | ||
| Schizophrenia | 1 (1.1) | 0 | ||
| Type of pain§ (%) | 0.00 | More patients with cervical/lumbar radiculopathy in the intervention group‡ | ||
| Migraine | 4 (4.3) | 6 (6.5) | ||
| Osteoarthritis | 32 (34.4) | 41 (44.1) | ||
| Rheumatoid Arthritis | 1 (1.1) | 4 (4.3) | ||
| Cervical/lumbar Radic. | 30 (32.3) | 5 (5.4) | ||
| Diabetic Neuropathy | 3 (3.2) | 4 (4.3) | ||
| Fibromyalgia | 8 (8.6) | 11 (11.8) | ||
| Somatic dysfunction | 8 (8.6) | 11 (11.8) | ||
| GI/pelvic pain | 7 (7.5) | 11 (11.8) | ||
| Type of opioid§ | 0.24 | |||
| T #3 | 5 (5.4) | 1 (1.1) | ||
| Tramadol | 7 (7.5) | 9 (9.7) | ||
| Hydrocodone | 53 (57) | 53 (57) | ||
| Morphine | 8 (8.6) | 3 (3.2) | ||
| Oxycodone | 10 (10.8) | 15 (16.1) | ||
| Fentanyl | 4 (4.3) | 8 (8.6) | ||
| Methadone¶ | 6 (6.5) | 4 (4.3) | ||
| MME strata and number of patients at each strata† (%) | 0.94 | |||
| <20 | 3 (3.2) | 3 (3.2) | ||
| 20 to 49 | 43 (46.2) | 43 (46.2) | ||
| 50–99 | 29 (31.2) | 30 (32.3) | ||
| 100 to 149 | 4 (4.3) | 4 (4.3) | ||
| 150 – 199 | 4 (4.3) | 4 (4.3) | ||
| 200 to 249 | 3 (3.2) | 3 (3.2) | ||
| 250 to 299 | 1 (1.1) | 2 (2.2) | ||
| 300 to 349 | 5 (5.4) | 1 (1.1) | ||
| 350 to 399 | 0 | 1 (1.1) | ||
| 400 to 449 | 1 (1.1) | 2 (2.2) |